ClinicalTrials.gg
Drug

Rilonacept clinical trials

Also written KPL-914 and IL-1 Trap.

studies test it
25
open now
1
in phase 3
7
first study started
2004

How each study uses rilonacept is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the rilonacept studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Feb 2008 · ARCALYST · BLA 125249 (FDA, Drugs@FDA)
European Union
23 Oct 2009 · Rilonacept Regeneron (previously Arcalyst) · EMEA/H/C/001047 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rilonacept
22
Arcalyst
6
Rilonacept 160 mg
2
Arcalyst, IL-1 Trap
2

Development codes

KPL-914
3
IL-1 Trap
3

Studies by the year they started

24 studies that test it; most in 2009 (5)

Studies that test rilonacept, by start year
YearStudies
20041
20052
20061
20071
20082
20095
20113
20121
20133
20141
20171
20181
20191
20251

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
3
Phase 2
13
Phase 3
7
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 14

Regeneron Pharmaceuticals (9) · Kiniksa Pharmaceuticals (UK), Ltd. (2) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2) · Southern California Institute for Research and Education (1) · VA Office of Research and Development (1) · Boston University (1) · University of Colorado, Denver (1) · Montefiore Medical Center (1)

Often tested with

Tested in the same studies.

Mycophenolic Acid (1) · Indomethacin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test rilonacept.

Studies

Open first, then newest update. How each study uses rilonacept is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test rilonacept →

Codes

What other systems call rilonacept · ClinicalTrials.gg INT005322

  • MeSH (NLM) C531377rilonaceptConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 8K80YB5GMGRILONACEPTConfirmed FDA, NLM, Wikidata
  • RxNorm 763450Confirmed FDA, Wikidata
  • Wikidata Q7334300rilonaceptConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C84137RilonaceptOne source FDA
  • DrugBank DB06372One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.